Author details

Full Name

Deborah Collyar

Affiliation

Clinical Trials Information Project

ORCID

Career Start Year

1999

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37740559	Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia.	Clin Infect Dis	2024
36031403	Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials.	Clin Infect Dis	2023
37615880	Aiding the Adoption of Master Protocols by Optimizing Patient Engagement.	Ther Innov Regul Sci	2023
37843122	The Future Ain't What It Used to Beâ¿¦Out With the Oldâ¿¦In With the Better: Antibacterial Resistance Leadership Group Innovations.	Clin Infect Dis	2023
37073571	Exploration of a Potential Desirability of Outcome Ranking Endpoint for Complicated Intra-Abdominal Infections Using 9 Registrational Trials for Antibacterial Drugs.	Clin Infect Dis	2023
37333362	Concerted epithelial and stromal changes during progression of Barrett's Esophagus to invasive adenocarcinoma exposed by multi-scale, multi-omics analysis.	bioRxiv	2023
34633655	Do you mind if I record?: Perceptions and practice regarding patient requests to record clinic visits in oncology.	Cancer	2022
35439025	Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update.	J Clin Oncol	2022
36339622	Patient-reported outcomes labeling for oncology drugs: Multidisciplinary perspectives on current status and future directions.	Front Pharmacol	2022
35191017	"Is it cancer or not?" A qualitative exploration of survivor concerns surrounding the diagnosis and treatment of ductal carcinoma in situ.	Cancer	2022
35044810	CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer.	J Clin Oncol	2022
35146487	Can We Afford to Exclude Patients Throughout Health Technology Assessment?	Front Med Technol	2022
34505795	The importance and value of engaging patients in cancer research.	Future Oncol	2021
31492767	Patient Preferences for Use of Archived Biospecimens from Oncology Trials When Adequacy of Informed Consent Is Unclear.	Oncologist	2020
32594002	How Health Literacy Can Enhance the Design and Conduct of Clinical Trials from Consent to Conclusion.	Stud Health Technol Inform	2020
32732671	The Cancer Journal Article for Theme Issue: The Problem of Cancer Drug Costs.	Cancer J	2020
32120064	The impact of patient characteristics and lifestyle factors on the risk of an ipsilateral event after a primary DCIS: A systematic review.	Breast	2020
32442291	Consensus on Language for Advance Informed Consent in Health Care-Associated Pneumonia Clinical Trials Using a Delphi Process.	JAMA Netw Open	2020
31150316	Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx.	J Clin Oncol	2019
31182655	Secondary Use of Patient Tissue in Cancer Biobanks.	Oncologist	2019
30862637	The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).	BMJ Open	2019
30646295	Assessment of the Perceived Acceptability of an Early Enrollment Strategy Using Advance Consent in Health Care-Associated Pneumonia.	JAMA Netw Open	2018
28864724	Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity.	Clin Cancer Res	2017
31360834	Gene Expression Assays for Early-Stage Hormone Receptor-Positive Breast Cancer: Understanding the Differences.	JNCI Cancer Spectr	2017
29149611	Core Clinical Data Elements for Cancer Genomic Repositories: A Multi-stakeholder Consensus.	Cell	2017
29141657	Local estrogen axis in the human bone microenvironment regulates estrogenÂ receptor-positiveÂ breast cancer cells.	Breast Cancer Res	2017
28591102	How direct-to-patient research can improve interest in clinical trials.	Clin Adv Hematol Oncol	2017
28692382	Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.	J Clin Oncol	2017
28864727	Immuno-oncology Clinical Trial Design: Limitations, Challenges, and Opportunities.	Clin Cancer Res	2017
28864725	The Challenge for Development of Valuable Immuno-oncology Biomarkers.	Clin Cancer Res	2017
26858339	Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.	J Clin Oncol	2016
28186948	Patient and physician attitudes regarding risk and benefit in streamlined development programmes for antibacterial drugs: a qualitative analysis.	BMJ Open	2016
27169770	Surgeons' Perspectives of Contralateral Prophylactic Mastectomy.	Ann Surg Oncol	2016
25092775	Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance).	J Clin Oncol	2015
26062394	A renaissance in biomedical innovation: global villages raise effective therapies.	Future Med Chem	2015
25638556	Outcomes and endpoints in cancer trials: bridging the divide.	Lancet Oncol	2015
25125258	Design of phase I combination trials: recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee.	Clin Cancer Res	2014
23409875	Community needs, concerns, and perceptions about health research: findings from the clinical and translational science award sentinel network.	Am J Public Health	2013
22415847	Ethical aspects of participation in the database of genotypes and phenotypes of the National Center for Biotechnology Information: the Cancer and Leukemia Group B Experience.	Cancer	2012
22392584	Patient advocates' role in clinical trials: perspectives from Cancer and Leukemia Group B investigators and advocates.	Cancer	2012
21672895	Biospecimens and people: a fundamental connection.	J Natl Cancer Inst Monogr	2011
20406927	Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology.	J Clin Oncol	2010
21037875	Issues surrounding biospecimen collection and use in clinical trials.	J Oncol Pract	2010
20808561	Cancer genomics: conducting exemplary trials with biospecimen and biomarker components.	J Oncol Pract	2010
18543100	The impact of sharing results of a randomized breast cancer clinical trial with study participants.	Breast Cancer Res Treat	2009
19367248	A patient advocate perspective on oncology drug development.	Clin Adv Hematol Oncol	2009
19470930	American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.	J Clin Oncol	2009
18559584	Patient perspectives on phase 0 clinical trials.	Clin Cancer Res	2008
18929153	An essential partnership: patient advocates and cooperative groups.	Semin Oncol	2008
15630417	How have patient advocates in the United States benefited cancer research?	Nat Rev Cancer	2005

1 - 50 of 56

Jacqui Gath

University of Leeds

Career Start Year 2015

Number of shared co-authors 0

Padma S Rajagopal

National Cancer Institute, National Institutes of Health

Career Start Year 2014

Number of shared co-authors 0

Donna R Rivera

Oncology Center of Excellence

Career Start Year 2012

Number of shared co-authors 0

Laura A Levit

Center for Research and Analytics, American Society of Clinical Oncology

Career Start Year 2010

Number of shared co-authors 4

Jeremy L Warner

Vanderbilt University Medical Center

Career Start Year 2009

Number of shared co-authors 0

Kelley M Kidwell

University of Michigan School of Public Health ann arbor

Career Start Year 2009

Number of shared co-authors 0

Gideon M Blumenthal

Oncology Center of Excellence

Career Start Year 2008

Number of shared co-authors 1

Julia A Beaver

Center for Drug Evaluation and Research

Career Start Year 2007

Number of shared co-authors 2

Peter Paul Yu

Hartford HealthCare Cancer Institute

Career Start Year 2006

Number of shared co-authors 2

Travis Osterman

Vanderbilt University Medical Center

Career Start Year 2004

Number of shared co-authors 0

Kathryn J Ruddy

Mayo Clinic

Career Start Year 2004

Number of shared co-authors 6

Nancy Roach

Marti Nelson Cancer Foundation

Career Start Year 2003

Number of shared co-authors 3

June M McKoy

Feinberg School of Medicine, Northwestern University

Career Start Year 2003

Number of shared co-authors 0

Philippe L Bedard

Princess Margaret Cancer Centre, University Health Network

Career Start Year 2002

Number of shared co-authors 6

Gregory R Pond

Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute

Career Start Year 2001

Number of shared co-authors 1

Stacy W Gray

City of Hope Comprehensive Cancer Center

Career Start Year 1998

Number of shared co-authors 5

Elizabeth Garrett-Mayer

Center for Research and Analytics, American Society of Clinical Oncology

Career Start Year 1997

Number of shared co-authors 4

Deborah Schrag

Memorial-Sloan Kettering Cancer Center

Career Start Year 1996

Number of shared co-authors 6

Kevin P Weinfurt

Center for Health Measurement, Duke University

Career Start Year 1996

Number of shared co-authors 3

Nikolajs Zeps

Queensland University of Technology

Career Start Year 1996

Number of shared co-authors 0

Giuseppe Curigliano

University of Milan

Career Start Year 1996

Number of shared co-authors 7

Jeff A Sloan

Mayo Clinic

Career Start Year 1991

Number of shared co-authors 7

Ramona F Swaby

Merck & Co., Inc.

Career Start Year 1991

Number of shared co-authors 0

Lois Shepherd

Queens University

Career Start Year 1991

Number of shared co-authors 4

Patricia A Deverka

Deverka Consulting LLC

Career Start Year 1991

Number of shared co-authors 1

Mark Lawler

Queens University Belfast Belfast

Career Start Year 1988

Number of shared co-authors 2

Charles L Bennett

University of South Carolina

Career Start Year 1986

Number of shared co-authors 2

Benjamin Djulbegovic

Medical University of South Carolina

Career Start Year 1985

Number of shared co-authors 0

Mark N Levine

Juravinski Hospital and Cancer Center

Career Start Year 1983

Number of shared co-authors 2

Jonathan Kimmelman

McGill University

Career Start Year 1977

Number of shared co-authors 3

row(s) 1 - 30 of 30

Jeffrey Peppercorn

Massachusetts General Hospital, Harvard Medical School

Co-authored papers 8

Vance G Fowler

Duke University School of Medicine

Co-authored papers 6

Eric P Winer

Dana-Farber Cancer Institute

Co-authored papers 5

Scott R Evans

Milken Institute School of Public Health, George Washington University

Co-authored papers 4

Fay J Hlubocky

Maclean Center for Clinical Medical Ethics, University of Chicago Medicine

Co-authored papers 4

Antonio C Wolff

Co-authored papers 4

Vered Stearns

Co-authored papers 3

Minetta C Liu

Co-authored papers 3

Sara M Tolaney

Dana-Farber Cancer Institute

Co-authored papers 2

Ian E Krop

Co-authored papers 2

Charles M Perou

Co-authored papers 2

Katharine Quain

Massachusetts General Hospital

Co-authored papers 2

Terry Hyslop

Co-authored papers 2

Debra J H Mathews

Carlsberg Laboratory, Case Western Reserve University, Johns Hopkins Medicine, Johns Hopkins School of Medicine, Johns Hopkins School of Public Health, Johns Hopkins University, National Academy of Sciences, Pennsylvania State University, Presidential Commission for the Study of Bioethical Issues

Co-authored papers 2

Steven J Isakoff

Massachusetts General Hospital

Co-authored papers 2

David G Pfister

Memorial Sloan Kettering Cancer Center

Co-authored papers 2

Eric G Campbell

Center for Bioethics and Humanities, University of Colorado School of Medicine

Co-authored papers 2

Nora Horick

Massachusetts General Hospital